English | Español
Patient Daily | Dec 19, 2025

Johnson & Johnson receives FDA priority voucher for multiple myeloma drug combination
Patient Daily | Dec 19, 2025

FDA approves first-line use of Enhertu for metastatic HER2-positive breast cancer
Patient Daily | Dec 19, 2025

Ambros raises $125M to bring Italian non-opioid pain drug to U.S. market
Patient Daily | Dec 19, 2025

Sanofi partners with South Korea's ADEL in $1B+ Alzheimer's drug development deal
Patient Daily | Dec 19, 2025

Ohio State trauma team helps soccer player return after gun violence injury
Patient Daily | Dec 19, 2025

AI helps identify new neuron types involved in covert visual attention
Patient Daily | Dec 19, 2025

Study reveals distinct roles for regulatory t cells in colorectal cancer prognosis
Patient Daily | Dec 19, 2025

Johns Hopkins researchers find chemotherapy may target latent HIV-infected immune cells

Trending
+ Regulatory
Patient Daily | Mar 30, 2026

Freedom Foundation CEO Meeks on 340B: 'The program has morphed into a veritable ATM for hospitals'
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

FDA’s new priority voucher program faces questions over transparency and selection process
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Researchers identify hormone-driven growth in lethal pediatric brain tumor
+ Regulatory
Patient Daily | Mar 30, 2026

Biotechnology Innovation Organization survey finds strong voter support for PBM reforms